Purchasing GLP-1 treatments in the North
Summary
This episode explores the high cost of weight loss medications in Ireland, prompting patients to travel to Northern Ireland for cheaper prescriptions due to VAT differences. Reporter Una Kelly interviews a patient, a community pharmacist, and a GP who discuss the financial barriers, the growing demand for these drugs, and the health benefits observed. The segment also highlights warnings from health authorities against sourcing unregulated medications online, emphasizing the importance of professional medical oversight.
Topics discussed
Introduction: Weight loss drugs and cross-border sourcing
Current HSE reimbursement status for weight loss drugs
Private pricing of Monjaro and Wegovy in Ireland
Patient story: Irina Finnegan's diagnosis and Ozempic use
Switching to Monjaro and discovering high costs
Financial barriers and decision to travel north
Logistics of obtaining medication in Northern Ireland
Explaining the price differential: VAT differences
Pharmacist perspective on cross-border patient trends
Historical VAT rules and pharmacy discount strategies
Clinical assessment requirements and rising patient demand
Clinical outcomes: Weight loss and improved blood tests
GP advice on cross-border prescriptions and pricing
Risks of sourcing medication from unregulated online sources
HPRA warning on safety and quality of online drugs
Listen ad-free on Castria